# Growth and Development Study of Alglucosidase Alfa

> **NCT00486889** · PHASE4 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 12 (actual)

## Conditions studied

- Pompe Disease
- Glycogen Storage Disease Type II (GSD-II)
- Acid Maltase Deficiency Disease

## Interventions

- **BIOLOGICAL:** alglucosidase alfa

## Key facts

- **NCT ID:** NCT00486889
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-26
- **Primary completion:** 2021-11-23
- **Final completion:** 2021-11-23
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486889, "Growth and Development Study of Alglucosidase Alfa". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00486889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*